Acceleron
is a Massachusetts-based biopharmaceutical company that develops and commercializes therapies for the treatment of pulmonary and hematologic diseases... Read moreAcceleron
is a Massachusetts-based biopharmaceutical company that develops and commercializes therapies for the treatment of pulmonary and hematologic diseases... Read more
News
Apr 10, 2024
Pharamceutical Technology
Acceleron: Acceleron Pharma gets grant for treatment of spinal muscular atrophy using ALK4:ACTIRiib antagonists
Oct 10, 2022
PharmaLive
Acceleron: Merck's blood vessel disorder drug succeeds in late-stage study
Mar 31, 2022
endpts
Acceleron: Merck chopping 140-plus staffers out of Acceleron in wake of $11.5B buyout
Nov 24, 2021
PharmiWeb
Acceleron: Merck Completes Acquisition of Acceleron Pharma Inc.
Nov 22, 2021
MarketScreener
Acceleron: Acceleron Pharma : Completion of Acquisition or Disposition of Assets - Form 8-K
Nov 20, 2021
Acrofan
Acceleron: Merck Completes Tender Offer to Acquire Acceleron Pharma Inc.
Nov 05, 2021
BioSpace
Acceleron: Acceleron Reports Third Quarter 2021 Financial Results
Oct 31, 2021
Citybizlist
Acceleron: Merck Announces Extension of Tender Offer to Acquire Acceleron Pharma
Oct 29, 2021
MarketScreener
Acceleron: Merck Announces Withdrawal and Refiling under the Hart-Scott-Rodino Act and Extension of Tender Offer to Acquire Acceleron Pharma Inc.
Oct 28, 2021
Business Wire
Press Release: Acceleron : Avoro Capital Issues Open Letter to Fellow Acceleron Pharma Shareholders
Acceleron Competitors
1
2
3
4
5
6
7
8
9
10